866-997-4948(US-Canada Toll Free)

Radiopharmaceuticals Market (Generators, PET & SPECT radioiosotopes, Technetium-99m, Gallium-67, Iodine-123, 18F-FDG, Rubidium-82, Yttrium-90 and others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

Published By :

Transparency

Published Date : Feb 2013

Category :

Generator

No. of Pages : 119 Pages


Radiopharmaceuticals imply the usage of radiation for non-invasive treatment and diagnosis of various diseases. Utilization of these molecules for medical purposes in PET and SPECT imaging has changed the entire algorithm of disease diagnosis. With rise in the aging population globally coupled with increasing rate of chronic cardiovascular, oncology and neurology diseases, there is tremendous growth potential in this market, especially in developing nations. Similarly, the use of radiolabeled isotopes with peptides and monoclonal antibodies has opened new boulevards for the growth of the global radiopharmaceuticals market. Many radiopharmaceuticals use technetium-99m (Tc-99m) that has many useful properties of gamma-emitting tracer nuclide.

Radiopharmaceuticals are majorly used to diagnose cancer, tumors, biliary tract blockage, bone diseases, bone marrow diseases, brain diseases, colorectal disease, disorders of iron metabolism and absorption, heart disease, heart muscle damage (infarct), impaired flow of cerebrospinal fluid in the brain, kidney diseases, liver diseases, lung diseases, parathyroid diseases, parathyroid cancer, pernicious anemia, improper absorption of vitamin B12 from intestines, red blood cell diseases, salivary gland diseases, spleen diseases, stomach and intestinal bleeding, stomach problems, tear duct blockage, thyroid diseases, thyroid cancer and urinary bladder diseases. 

This may be given to the patient in a number of ways, for e.g. they may be given through the mouth, through injections or placed into the eye or into the bladder. It is a small treatment, which includes use of simple substances containing radioactive isotopes. While treating cancer, these radioactive agents are taken up in the cancerous area to destroy the affected tissues. It works effectively by targeting the areas in the body where the cancer is present. Individuals are suggested to intake radiopharmaceuticals only under the direct supervision of a doctor. 

This report analyses the global scenario of the radiopharmaceuticals market, discussing detailed overview and market figures. The research report analyses the industry growth rate, industry capacity, and industry structure. The report analyses the historical data, and forecasts the radiopharmaceuticals market size, production forecasts along with key factors driving and restraining the market.

The report also analyzes the radiopharmaceuticals market by generators and by further classifying them in terms of medical isotopes, their applications, end users and geographic distribution. The medical isotopes category covers major isotopes used in SPECT and PET imaging like technetium, thallium, gallium, rhenium, yttrium and others. The applications market is further classified into diagnosis and therapy. The end user analysis is done by bifurcation of the market into hospitals and outpatient diagnostic centers.

The geography market has been segmented into four major regions - North America, Europe, Asia-Pacific and Rest of the World (RoW). Some of the top radiopharmaceutical companies in the healthcare market are Covidien Plc, Nordion Inc., Lantheus Medical Imaging, IBA Group, Positron Corporation, Cardinal Health, Eckert & Ziegler among others.

The study presents a comprehensive assessment of the stakeholder strategies, winning imperatives for them by segmenting the radiopharmaceuticals market as below:

Radiopharmaceuticals Market by Generator Types
  • Mo-99/Tc-99m generator
  • Sr-82/Rb-82 generator
  • Ge-68/Ga-68 generator
  • Sr-90/Y-90 generator
  • W-188/Re-188 generator
  • Radiopharmaceuticals Market by End-Users
  • Hospitals & Medical Centers
  • Diagnostic Centers
  • Radiopharmaceuticals Market by Applications

Diagnosis

Diagnosis by Technique

SPECT
  • Technetium (Tc-99m)
  • Thallium (TI-201)
  • Gallium (Ga-67)
  • Iodine (I-123)
  • Rhenium (Re-186)
  • Yttrium (Y-90)
  • Others
  • PET
  • Fludeoxyglucose (18F-FDG)
  • Rubidium (Rb-82)
  • Others (Carbon-11 choline, Nitrogen-13 ammonia)
Diagnosis by Indications
  • Oncology
  • Cardiovascular
Others (Neurological, Thyroid, Gastrointestinal)

Therapy
  • Systemic Oncology
  • Iodine (I-131)
  • Yttrium (90Y)
  • Samarium (Sm-153)
  • Strontium (89Sr)
  • Rhenium (186Re)
  • Lutetium (Lu-177)
  • Erbium (169Er)
  • Others
Others (Cardiology, Neurology)

Radiopharmaceuticals Market by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
TABLE OF CONTENTS

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Global Radiopharmaceuticals Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Radiopharmaceutical-Based Cancer Therapy
3.2.2 Growing Preference For Disease-Targeted Therapy
3.2.3 Increasing Awareness Of Accurate Diagnosis
3.2.4 Expanding Molecular Imaging Applications
3.3 Market Restraints
3.3.1 Strict Regulatory Guidelines For Production, Storage and Usage
3.3.2 Worldwide Supply Shortages
3.3.3 Price Sensitivity And Competitive Alternatives
3.4 Market Opportunities
3.4.1 Increasing Demand For Accurate Diagnosis and Treatment, Particularly In Emerging Markets
3.4.2 Radiopharmaceutical-Based Personalized Therapy

Chapter 4 Market Definition & Supply Chain Analysis
4.1 Market Definition
4.2 Radiopharmaceutical Production : A Global Perspective
4.3 Supply Chain Analysis

Chapter 5 Global Radiopharmaceutical Generators Market
5.1 Overview
5.1.1 Global Radiopharmaceutical Generators Market, By Revenue, 2010-2018 (USD Million)
5.2 Mo-99/Tc-99m Generators
5.3 Sr-82/Rb-82 Generators
5.4 Ge-68/Ga-67,68 Generators
5.5 Sr-90/Y-90 Generators
5.6 W-188/Re-188 Generators

Chapter 6 Global Radiopharmaceuticals Market, By End-User Groups
6.1 Overview
6.1.1 Global Radiopharmaceuticals Market By End Users, By Revenue, 2010-2018 (USD Million)
6.2 Hospitals and Medical Centers
6.2.1 Global Radiopharmaceuticals Market By End User Groups : Hospitals and Medical Centres, 2010 – 2018 (USD Million)
6.3 Outpatient Diagnostic Centers
6.3.1 Global Radiopharmaceuticals Market By End User Groups: Diagnostic Centres, 2010 – 2018 (USD Million)

Chapter 7 Global Radiopharmaceuticals Market, By Applications
7.1 Overview
7.2 Radiopharmaceuticals For Diagnosis
7.2.1 Overview
7.2.2 Radiopharmaceuticals For Diagnosis, By Technique
7.2.2.1 Single-Photon Emission Computed Tomography (SPECT)
7.2.2.1.1 Comparative Analysis: SPECT Radioisotopes Market, 2011 & 2018 (%)
7.2.2.1.2 Technetium (Tc-99m)
7.2.2.1.3 Thallium (Tl-201)
7.2.2.1.4 Gallium (Ga-67)
7.2.2.1.5 Iodine (I-123)
7.2.2.1.6 Rhenium (Re-186)
7.2.2.1.7 Yttrium (Y-90)
7.2.2.1.8 Others
7.2.2.2 Positron Emission Tomography (PET)
7.2.2.2.1 Comparative Analysis: PET Radioisotopes Market, 2011 & 2018 (%)
7.2.2.2.2 Fludeoxyglucose (18f-FDG)
7.2.2.2.3 Rubidium (Rb-82)
7.2.2.2.4 Others (Carbon-11 Choline, Nitrogen13 Ammonia)
7.2.3 Radiopharmaceuticals For Diagnosis, By Indications
7.2.3.1 Oncology
7.2.3.2 Cardiovascular
7.2.3.3 Others (Neurological, Thyroid, Gastrointestinal)
7.3 Radiopharmaceuticals For Therapy
7.3.1 Overview
7.3.2 Oncology (Systemic Therapy)
7.3.2.1 Comparative Analysis: Systemic Therapy Radioisotopes Market, 2011 & 2018 (%)
7.3.2.2 Iodine (I-131)
7.3.2.3 Yttrium (Y-90)
7.3.2.4 Samarium (Sm-153)
7.3.2.5 Strontium (Sr-89)
7.3.2.6 Rhenium (186Re)
7.3.2.7 Lutetium-177 (Lu-177)
7.3.2.8 Erbium-169 (169Er)
7.3.2.9 Others
7.3.3 Other Applications In Therapy (Cardiology, Neurology)
7.4 Theranostics

Chapter 8 Global Radiopharmaceuticals Market, By Geography
8.1 Overview
8.2 North America
8.2.1 North America Radiopharmaceuticals Market - Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
8.2.2 North America Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
8.3 Europe
8.3.1 Europe Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
8.3.2 Europe Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
8.4 Asia-Pacific (Apac)
8.4.1 Asia-Pacific Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
8.4.2 Asia-Pacific Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
8.5 Rest of the World (RoW)
8.5.1 RoW Radiopharmaceuticals Market- Diagnosis and Systemic Therapy, 2010-2018 (USD Million)
8.5.2 RoW Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)

Chapter 9 Market Share Analysis By Key Players
9.1 Radiopharmaceuticals Market
9.2 Generators Market

Chapter 10 Recommendations
10.1 Identification and Elimination Of Barriers
10.2 Development of Total Solutions
10.3 Investing in Emerging Markets
10.4 Entering Monopoly Markets

Chapter 11 Company Profiles
11.1 Cardinal Health Inc.
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Business Strategies
11.1.3.1 Mergers and Acquisitions
11.1.3.2 External Funding
11.1.3.3 Incorporation of Advanced Technologies to Support Business Development
11.1.4 Product Portfolio
11.1.5 Recent Developments
11.2 Covidien Plc
11.2.1 Company Overview
11.2.2 Product Portfolio
11.2.3 Financial Overview
11.2.4 Strategic Overview
11.2.4.1 Mergers and Acquisitions
11.2.4.2 Approvals
11.2.5 Recent Developments
11.3 GE Healthcare
11.3.1 Company Overview
11.3.2 Product Portfolio
11.3.3 Financial Overview
11.3.4 Strategic Overview
11.3.4.1 Mergers and Acquisitions
11.3.5 Recent Developments
11.4 IBA Group
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Product Portfolio
11.5 Lantheus Medical Imaging
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Business Strategies
11.5.3.1 Rigorous Research and Development Initiatives
11.5.3.2 Selling Generic Products to Maintain Market Share
11.5.4 Product Portfolio
11.5.4.1 Recent Developments
11.6 Monrol Nuclear Products, Inc.
11.6.1 Company Overview
11.6.2 Product Portfolio
11.6.3 Strategic Overview
11.6.3.1 Mergers and Acquisitions
11.6.3.2 Collaborations
11.6.4 Recent Developments
11.7 Nordion, Inc.
11.7.1 Company Overview
11.7.2 Product Portfolio
11.7.3 Financial Overview
11.7.4 Strategic Overview
11.7.4.1 Contracts and Agreements
11.7.4.2 Divestiture
11.7.5 Recent Developments
11.7.5.1 New Product Launch
11.8 NTP Radioisotopes (Pty) Ltd
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Business Strategies
11.8.3.1 Media Campaigns as a Brand Management Tool
11.8.3.2 Business Expansion through Partnerships, Collaborations and Alliances
11.8.4 Product Portfolio
11.8.5 Recent Developments
11.9 Polatom
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Business Strategies
11.9.3.1 Maintaining an Extensive Network of Distributors
11.9.4 Product Portfolio
11.9.5 Recent Developments
11.10 Positron Corporation
11.10.1 Company Overview
11.10.2 Product Portfolio
11.10.3 Financial Overview
11.10.4 Strategic Overview
11.10.4.1 Contracts and Agreements
11.10.4.2 Collaborations
11.10.5 Recent Developments
11.10.5.1 Grants and Licenses
11.10.5.2 Incentives
11.11 Siemens Healthcare
11.11.1 Company Overview
11.11.2 Financial Overview
11.11.3 Business Strategies
11.11.3.1 Investing In Emerging Economies
11.11.3.2 Rigorous Research and Development Initiatives
11.11.3.3 Identifying Key Growth Areas and Determining Short Term Goals (Agenda 2013)
11.11.3.4 Maintaining An Extensive Suppliers Network
11.11.4 Product Portfolio
11.11.5 Recent Developments

List of Table


Table 1 Global Radiopharmaceuticals Market By Region, 2010 – 2018 (USD Million)
Table 2 Global Radiopharmaceuticals Generators Market By Segments, 2010 – 2018 (USD Million)
Table 3 Global Radiopharmaceutical Generators Market, By Revenue, 2010-2018 (USD Million)
Table 4 Global Radiopharmaceuticals Market By End Users, By Revenue, 2010-2018 (USD Million)
Table 5 Global Radiopharmaceuticals Market, By Applications, 2010-2018 (USD Million)
Table 6 Global Radiopharmaceuticals Market, By Region, 2010 – 2018 (USD Million)
Table 7 Global Radiopharmaceuticals Market, By Diagnosis, 2010-2018 (USD Million)
Table 8 Global SPECT Market, By Radioisotopes, 2010-2018 (USD Million)
Table 9 Gallium Compounds: Ongoing Studies
Table 10 Global PET Market, By Radioisotopes, 2010-2018 (USD Million)
Table 11 Global Radiopharmaceuticals Therapy Market, By Indications, 2010-2018 (USD Million)
Table 12 Global Systemic Therapy Market, By Radioisotopes, 2010-2018 (USD Million)
Table 13 Radionuclides and Their Applications (Diagnostics/Therapies)
Table 14 Global Radiopharmaceuticals Market By Region, 2010 – 2018 (USD Million)
Table 15 North America Radiopharmaceuticals Market - Diagnosis And Systemic Therapy, 2010-2018 (USD Million)
Table 16 North America Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
Table 17 Europe Radiopharmaceuticals Market- Diagnosis And Systemic Therapy, 2010-2018 (USD Million)
Table 18 Europe Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
Table 19 Asia-Pacific Radiopharmaceuticals Market- Diagnosis And Systemic Therapy, 2010-2018 (USD Million)
Table 20 Asia-Pacific Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)
Table 21 RoW Radiopharmaceuticals Market- Diagnosis And Systemic Therapy, 2010-2018 (USD Million)
Table 22 RoW Diagnosis Radiopharmaceuticals Market 2010-2018 (USD Million)

List of Chart


Fig. 1 Radiopharmaceuticals Market Segmentation
Fig. 2 Global Radiopharmaceuticals Market Snapshot
Fig. 3 Global Radiopharmaceuticals Market, By Application, 2011 (USD Million)
Fig. 4 Radiopharmaceuticals Market Attractiveness Analysis, By Geography (2011)
Fig. 5 Global Demand For Tc-99m (2009)
Fig. 6 Supply Chain - Global Radiopharmaceuticals Market
Fig. 7 Global Mo-99/Tc-99m Generators Market, 2010 – 2018 (USD Million)
Fig. 8 Global Sr-82/Rb-82 Generators Market, 2010 – 2018 (USD Million)
Fig. 9 Global Ge-68/Ga-67,68 Generators Market, 2015 – 2018 (USD Million)
Fig. 10 Global Sr-90/Y-90 Generators Market, 2016 – 2018 (USD Million)
Fig. 11 Global W-188/Re-188 Generators Market, 2016 – 2018 (USD Million)
Fig. 12 Global Radiopharmaceuticals Market By End User Groups : Hospitals And Medical Centres, 2010 – 2018 (USD Million)
Fig. 13 Global Radiopharmaceuticals Market By End User Groups: Diagnostic Centres, 2010 – 2018 (USD Million)
Fig. 14 Comparative Analysis: SPECT Radioisotopes Market, 2011 & 2018 (%)
Fig. 15 Global Tc-99m Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 16 Global Tl-201 Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 17 Global Ga-67 Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 18 Global Iodine (I-123) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 19 Global Rhenium (Re-186) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 20 Global Yttrium (Y-90) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 21 Global Others (In SPECT) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 22 Comparative Analysis: PET Radioisotopes Market, 2011 & 2018 (%)
Fig. 23 Global Fludeoxyglucose (18f-FDG) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 24 Global Rubidium (Rb-82) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 25 Global Others (In PET) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 26 Comparative Analysis: Systemic Therapy Radioisotopes Market, 2011 & 2018 (%)
Fig. 27 Global Iodine (I-131) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 28 Global Yttrium (Y-90) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 29 Global Samarium (Sm-153) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 30 Global Strontium (Sr-89) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 31 Global Rhenium (186Re) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 32 Global Lutetium (Lu-177) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 33 Global Erbium (169Er) Radioisotope Market, 2010 – 2018 (USD Million)
Fig. 34 Global Other Applications In Therapy Radioisotopes Market, 2010 – 2018 (USD Million)
Fig. 35 Radiopharmaceuticals: Market Share Analysis Of Key Players, 2011 (%)
Fig. 36 Annual Revenues: Cardinal Health Inc., 2010 – 2012 (USD Million)
Fig. 37 Annual Revenues: Covidien Plc, 2009 – 2011 (USD Million)
Fig. 38 Annual Revenues: Ge Healthcare, 2009 – 2011 (USD Million)
Fig. 39 Annual Revenues: IBA Group, 2009 – 2011 (USD Million) (Conversion Rate: 1 Euro = 1.34 USD)
Fig. 40 Annual Revenues: Lantheus Medical Imaging, 2010 – 2011 (USD Million)
Fig. 41 Annual Revenues: Nordion, Inc., 2009 – 2011 (USD Million)
Fig. 42 Annual Revenues: Positron Corporation, 2009 – 2011 (USD Million)
Fig. 43 Annual Revenues: Siemens Healthcare, 2010 – 2011 (USD Million) (Conversion Rate: 1 Euro = 1.34 USD)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *